Phototherapy for Atopic Dermatitis in the Era of Biologics and JAK Inhibitors: Mechanisms, Protocols, Evidence, and Positioning

Biologics and Janus kinase (JAK) inhibitors have transformed the treatment of atopic dermatitis (AD), but phototherapy remains accessible, relatively inexpensive and free of systemic drug interactions. This narrative review synthesises mechanistic data, clinical trials, real-world studies and emerging evidence on phototherapy alongside targeted systemic therapies. Narrowband ultraviolet B (NB-UVB) and UVA1 can improve pruritus and disease activity in selected patients, although the evidence base is heterogeneous and many trials predate contemporary outcome measures. Retrospective data suggest that patients with moderate, intermittent disease may be more likely to benefit than those with severe, continuously active AD. Small studies of short-cycle NB-UVB added to dupilumab suggest faster early improvement, without a clear adverse-event signal in the limited available datasets; however, durable benefit and the absence of additional toxicity have not been established. Evidence for combining phototherapy with oral JAK inhibitors is largely extrapolated from non-AD settings and remains speculative. Phototherapy therefore retains a role as a selected treatment or adjunct when systemic therapy is unsuitable, undesired or not readily accessible. Proposed stage-specific combination and flare-control strategies should be regarded as hypothesis-generating and require prospective validation before they can be considered standard practice.

Authors

Institutions

Publication Details

Journal
Clinical and Experimental Dermatology
Published
2026-11-12
DOI
https://doi.org/10.1093/ced/llag478
Primary Topic
Dermatology and Skin Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Phototherapy for Atopic Dermatitis in the Era of Biologics and JAK Inhibitors: Mechanisms, Protocols, Evidence, and Positioning

Paulo Filipe, Rene C. Santus, Gustavo Almeida‐Silva, João Ferreira
Clinical and Experimental Dermatology
Dermatology and Skin Diseases
article

Phototherapy for Atopic Dermatitis in the Era of Biologics and JAK Inhibitors: Mechanisms, Protocols, Evidence, and Positioning

Paulo Filipe, Rene C. Santus, Gustavo Almeida‐Silva, João Ferreira
article en

Abstract

Biologics and Janus kinase (JAK) inhibitors have transformed the treatment of atopic dermatitis (AD), but phototherapy remains accessible, relatively inexpensive and free of systemic drug interactions. This narrative review synthesises mechanistic data, clinical trials, real-world studies and emerging evidence on phototherapy alongside targeted systemic therapies. Narrowband ultraviolet B (NB-UVB) and UVA1 can improve pruritus and disease activity in selected patients, although the evidence base is heterogeneous and many trials predate contemporary outcome measures. Retrospective data suggest that patients with moderate, intermittent disease may be more likely to benefit than those with severe, continuously active AD. Small studies of short-cycle NB-UVB added to dupilumab suggest faster early improvement, without a clear adverse-event signal in the limited available datasets; however, durable benefit and the absence of additional toxicity have not been established. Evidence for combining phototherapy with oral JAK inhibitors is largely extrapolated from non-AD settings and remains speculative. Phototherapy therefore retains a role as a selected treatment or adjunct when systemic therapy is unsuitable, undesired or not readily accessible. Proposed stage-specific combination and flare-control strategies should be regarded as hypothesis-generating and require prospective validation before they can be considered standard practice.

Clinical and Experimental Dermatology
University of Lisbon (PT), Centro Hospitalar Lisboa Norte (PT), Muséum national d'Histoire naturelle (FR), Hospital de Santa Maria (PT)
Dermatology and Skin Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon